After a sluggish year in 2020 for mergers and acquisitions among hospitals and health systems, 2021 has shown renewed vigor and is poised for considerable transactional activity.
USA, Competition & Antitrust, Corporate Finance/M&A, Healthcare & Life Sciences, Insolvency & Restructuring, Morgan, Lewis & Bockius LLP, Medicare, Medicaid, Supply chain, Telemedicine, Coronavirus, Personal protective equipment, Paycheck Protection Program, Federal Trade Commission (USA), Consumer Financial Protection Bureau (USA), US Department of Justice, Affordable Care Act 2010 (USA), CARES Act 2020 (USA)
In preparation for a post COVID-19 world, Chinese outbound investors have begun to source for bargain deals in other countries, with markets characterised by corporate restructurings, low prices, depressed valuations, distressed assets, and fire sales. In this article, we briefly set out some suggestions for Chinese outbound investors when entering into bargain M&A deals in this unprecedented M&A landscape.
China, Corporate Finance/M&A, Insolvency & Restructuring, King & Wood Mallesons, Due diligence, Force majeure, Coronavirus